Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CODX Co-Diagnostics, Inc.

Pre-Mkt 04-10 05:05:52 EDT

1.44

+0.05

+3.60%

盘前1.43

-0.01-0.69%

04:07 EDT

High1.50	Low1.35	Vol201.24K
Open1.39	D1 Closing1.39	Amplitude10.79%
Mkt Cap5.19M	Tradable Cap5.04M	Total Shares3.60M
T/O285.23K	T/O Rate5.75%	Tradable Shares3.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CODX","market":"US","secType":"STK","nameCN":"Co-Diagnostics, Inc.","latestPrice":1.44,"timestamp":1775764800000,"preClose":1.39,"halted":0,"volume":201243,"hourTrading":{"tag":"盘前","latestPrice":1.43,"preClose":1.44,"latestTime":"04:07 EDT","volume":34,"amount":48.5399946,"timestamp":1775808425774,"change":-0.01,"changeRate":-0.006944,"amplitude":0.006944},"delay":0,"changeRate":0.03597122302158277,"floatShares":3499300,"shares":3602465,"eps":-35.2548,"marketStatus":"Pre-Mkt","change":0.05,"latestTime":"04-10 05:05:52 EDT","open":1.39,"high":1.5,"low":1.35,"amount":285233.3156211,"amplitude":0.107914,"askPrice":1.62,"askSize":100,"bidPrice":1.27,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-35.2548,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775827800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.44,"preHourTrading":{"tag":"盘前","latestPrice":1.43,"preClose":1.44,"latestTime":"04:07 EDT","volume":34,"amount":48.5399946,"timestamp":1775808425774,"change":-0.01,"changeRate":-0.006944,"amplitude":0.006944},"postHourTrading":{"tag":"盘后","latestPrice":1.4421,"preClose":1.44,"latestTime":"19:54 EDT","volume":3922,"amount":5645.9267,"timestamp":1775778855496,"change":0.0021,"changeRate":0.001458,"amplitude":0.019306},"volumeRatio":1.272699100527628,"impliedVol":1.6193,"impliedVolPercentile":0.4973},"requestUrl":"/m/hq/s/CODX/wiki","defaultTab":"wiki","newsList":[{"id":"2626187472","title":"Co-Diagnostics executives join WTC Utah trade mission with Governor Cox","url":"https://stock-news.laohu8.com/highlight/detail?id=2626187472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626187472?lang=en_us&edition=fundamental","pubTime":"2026-04-09 21:04","pubTimestamp":1775739880,"startTime":"0","endTime":"0","summary":"Co-Diagnostics executives will join World Trade Center Utah trade mission with Utah Governor Cox across Switzerland, April 13-22.Participation will extend to meetings with prospective customers, April 2026 at ESCMID Global 2026 in Munich.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on April 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL6KJ0cB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624779504","title":"BRIEF-Co-Diagnostics Joint Venture Comira Receives Approval For Manufacturing Facility In Kingdom Of Saudi Arabia's Sudair Industrial City","url":"https://stock-news.laohu8.com/highlight/detail?id=2624779504","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624779504?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:42","pubTimestamp":1775137321,"startTime":"0","endTime":"0","summary":"BRIEF-Co-Diagnostics Joint Venture Comira Receives Approval For Manufacturing Facility In Kingdom Of Saudi Arabia's Sudair Industrial CityApril 2 (Reuters) - Co-Diagnostics Inc CODX.O:CO-DIAGNOSTICS J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40L0G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624350164","title":"Co-Diagnostics Joint Venture Comira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City","url":"https://stock-news.laohu8.com/highlight/detail?id=2624350164","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624350164?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:01","pubTimestamp":1775134912,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40L0G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624053748","title":"Co-Diagnostics FY25 net loss widens to $47M; revenue drops to $0.6M","url":"https://stock-news.laohu8.com/highlight/detail?id=2624053748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624053748?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:10","pubTimestamp":1774987829,"startTime":"0","endTime":"0","summary":"Co-Diagnostics posted a net loss of $47 million, compared with a net loss of $38 million a year earlier.Revenue fell to $0.6 million from $3.9 million, primarily due to lower grant revenue.Adjusted EBITDA loss narrowed to $28 million from $33.5 million.Cash, cash equivalents, and marketable investment securities declined to $11.9 million from $29.7 million.Dwight Egan said Co-Diagnostics is planning an initial FDA 510 submission for an upper respiratory test focused on flu A, flu B, and RSV, citing reduced COVID prevalence in clinical study locations.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL94C1SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624641537","title":"Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2624641537","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624641537?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:07","pubTimestamp":1774987655,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent decrease over losses of $(10.82) per share from the same period last year.  The company reported $263.922 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51583210/co-diagnostics-q4-eps-16-65-down-from-10-82-yoy-sales-263-922k-up-from-149-325k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624353785","title":"Press Release: Co-Diagnostics Reports Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2624353785","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624353785?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:01","pubTimestamp":1774987260,"startTime":"0","endTime":"0","summary":"Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures. Progressing Clinical Pipeline and Regulatory Pathways for PCR Platform. Strengthening Technology Leadership with AI Integration and Expanding IP Portfolio. SALT LAKE CITY, March 31, 2026 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its financial results for the full year ended December 31, 2025.-- Revenue of $0.6 million, compared to $3.9 million in 2024, primarily due. -- Operating expenses of $50.6 million, compared to $43.0 million in 2024,driven by a non-cash impairment charge of $18.9 million from revaluation. $37.6 million, or $37.22 per share in 2024, primarily due to intangible. asset impairment charges and lower grant revenue, partially offset by. decreases in operating expenses and a benefit from income taxes. $11.9 million as of December 31, 2025, compared to $29.7 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","R","BK4568","03160","BK4022","BK4585","BK4588","CODX","TM","BK4082","BK4555","BK4232","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622808660","title":"Co-Diagnostics Inc  expected to post a loss of $3.60 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622808660","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622808660?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:23","pubTimestamp":1774642999,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc  expected to post a loss of $3.60 a share - Earnings Preview Co-Diagnostics Inc CODX.OQ CODX.O is expected to  show a fall in quarterly revenue when it reports  results on March 31 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F210:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622073621","title":"Co-Diagnostics ships PCR Pro instruments and TB test kits to India; clinical performance studies near-term initiation expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2622073621","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622073621?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:03","pubTimestamp":1774440234,"startTime":"0","endTime":"0","summary":"Co-Diagnostics ships PCR Pro instruments and TB test kits to India; clinical performance studies near-term initiation expected. Co-Diagnostics said it commenced shipments of PCR Pro instruments, Co-Dx PCR MTB test kits for tuberculosis, and proprietary sample preparation instruments to its joint venture CoSara Diagnostics in India.The shipments are intended to support the initiation of clinical performance studies for the tuberculosis test on the PCR platform as the company completes final steps toward starting those studies in the near term.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL7hN2pZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621133755","title":"Co-Diagnostics (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2621133755","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621133755?lang=en_us&edition=fundamental","pubTime":"2026-03-21 02:00","pubTimestamp":1774029610,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 20th, 2026, FinanceWire Co-Diagnostics (NASDAQ:CODX) announced that its Indian joint venture, Co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/co-diagnostics-nasdaq-codx-expands-cosara-distribution-territory-across-south-asia?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/co-diagnostics-nasdaq-codx-expands-cosara-distribution-territory-across-south-asia?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TQQQ","JEPQ","GPIQ","QQQE","QID","USAW.SI","QQQJ","TSYW.SI","SQQQ","USJW.SI","QQQY","CODX",".IXIC","BK4568","NVIW.SI","NQmain","PSQ","BK4082","MNQmain","QYLG","QLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621254758","title":"Nasdaq Down Over 1%; XPeng Shares Fall After Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2621254758","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621254758?lang=en_us&edition=fundamental","pubTime":"2026-03-21 00:33","pubTimestamp":1774024424,"startTime":"0","endTime":"0","summary":"U.S. stocks traded lower, with Dow falling over 100 points. Energy shares climbed 1%, while consumer stocks dropped 1.3%. Xpeng shares fell 7% after weak sales results. Scholastic soared 12% and Super Micro Computer dropped 27%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/03/51384244/nasdaq-down-over-1-xpeng-shares-fall-after-q4-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","XPEV","BK4123","BARK","BK4122","PLU","BK4170","BK4526","XPEG","BK4157","BK4111","BK4099","LU0053671581.USD","LU1861215975.USD","BK4555","CODX","UMAC","SMCC","SMCY","BK4505","BK4082","BK4603","BK4588","SMYY","BK4543","BK4200","EVS.SI","SMCX","SMCZ","SCHL","SMCL","BK4568","LU1861220033.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620692735","title":"Co-Diagnostics to expand commercial, distribution territory across South Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2620692735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620692735?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:11","pubTimestamp":1774008717,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) has signed an agreement for CoSara Diagnostics, the Indian joint venture between Co-Dx and Ambalal Sarabhai Enterprises, to s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-to-expand-commercial-distribution-territory-across-south-asia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-to-expand-commercial-distribution-territory-across-south-asia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620733458","title":"CoSara Diagnostics expands South Asia territory, targets USD 13 billion market opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2620733458","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620733458?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:02","pubTimestamp":1774008163,"startTime":"0","endTime":"0","summary":"CoSara, an Indian joint venture between Co-Dx and ASE Group, signed an agreement to expand its commercial and distribution territory in South Asia to include Bangladesh, Pakistan, Nepal, and Sri Lanka.The expanded territory increased CoSara’s estimated regional addressable market opportunity to USD 13 billion.Plans include establishing distribution channels in the newly added markets while evaluating regulatory pathways and engaging regional distribution partners.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL5xZ30s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620733577","title":"Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2620733577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620733577?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:00","pubTimestamp":1774008000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nTUA95VCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620427468","title":"Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2620427468","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620427468?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:04","pubTimestamp":1773752647,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast               Co-Diagnostics will release its fourth quarter and full year 2025 financial results on March 31, 2026, af","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9ScK8l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619465552","title":"Co-Diagnostics to present at Medical Korea 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619465552","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619465552?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:01","pubTimestamp":1773666080,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on March 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL554k5v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618068132","title":"Co-Diagnostics receives Japanese patent No. 7797537 for Co-Dx PCR platform technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2618068132","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618068132?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:08","pubTimestamp":1773320917,"startTime":"0","endTime":"0","summary":"Co-Diagnostics said the Japan Patent Office granted Japanese Patent No. 7797537 titled “Systems, Methods, and Apparatus for Automated Self-Contained Biological Analysis.” The patent includes 34 claims covering automated, self-contained biological analysis methods and apparatus used in the Co-Dx PCR Pro system, including the instrument and its test cups. Co-Diagnostics said the patent was initially registered on December 26, 2025 and was filed under the Patent Cooperation Treaty. The company also referenced an Australian patent grant in 2025 covering related Co-Dx PCR platform technologies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief on March 12, 2026","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL2rBstt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618928349","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928349","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928349?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:30","pubTimestamp":1773235827,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nAQN2LPO7B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4082","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618495351","title":"Co-Diagnostics Regains Compliance With Nasdaq Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2618495351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618495351?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:00","pubTimestamp":1773147658,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nTUAPBXL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610563546","title":"Co-Diagnostics Forms Joint Venture with Arabian Eagle Manufacturing for MENA Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2610563546","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610563546?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:02","pubTimestamp":1770645731,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. has entered into a joint venture with Arabian Eagle Manufacturing, forming CoMira Diagnostics in the Kingdom of Saudi Arabia. This partnership aims to localize the manufacturing and distribution of Co-Diagnostics' technologies and intellectual property across Saudi Arabia and 18 additional countries in the Middle East and North Africa  region. The collaboration is part of Co-Diagnostics' strategy to expand access to high-quality molecular diagnostics throughout the region.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDLlmVfm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609306504","title":"Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture PCR Pro Instrument in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2609306504","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609306504?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:01","pubTimestamp":1770300105,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc. announced that its joint venture, CoSara Diagnostics Pvt. Ltd. , has received a license from the Central Drugs Standard Control Organization  to manufacture the CoSara PCR Pro real-time PCR point-of-care instrument at its facility in Ranoli, India. The CDSCO license, issued on Form MD-5, authorizes the manufacturing and sale or distribution of the CoSara-branded Class A medical device instrument. This represents the final instrument license required by CDSCO before commercialization can begin. CoSara PCR test kits to be used with the instrument, such as those for Mycobacterium tuberculosis  and human papillomavirus , require separate regulatory clearance and are not yet available for sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDLDfdBs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.codiagnostics.com","stockEarnings":[{"period":"1week","weight":-0.0649},{"period":"1month","weight":-0.6727},{"period":"3month","weight":-0.7674},{"period":"6month","weight":-0.8734},{"period":"1year","weight":-0.8563},{"period":"ytd","weight":-0.7153}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.280232},{"month":2,"riseRate":0.222222,"avgChangeRate":0.209425},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.179204},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.017943},{"month":5,"riseRate":0.375,"avgChangeRate":0.046537},{"month":6,"riseRate":1,"avgChangeRate":0.106921},{"month":7,"riseRate":0.625,"avgChangeRate":0.172835},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.06719},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.02377},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.003584},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.082815},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.196965}],"exchange":"NASDAQ","name":"Co-Diagnostics, Inc.","nameEN":"Co-Diagnostics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Co-Diagnostics, Inc.,CODX,Co-Diagnostics, Inc.股票,Co-Diagnostics, Inc.股票老虎,Co-Diagnostics, Inc.股票老虎国际,Co-Diagnostics, Inc.行情,Co-Diagnostics, Inc.股票行情,Co-Diagnostics, Inc.股价,Co-Diagnostics, Inc.股市,Co-Diagnostics, Inc.股票价格,Co-Diagnostics, Inc.股票交易,Co-Diagnostics, Inc.股票购买,Co-Diagnostics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Co-Diagnostics, Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Co-Diagnostics, Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}